For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Other products in this section:
The AI revolution is here. Will you lead or follow?
Join us at EmTech Digital 2019.
We can now customize cancer treatments, tumor by tumor
But can any company afford to manufacture one-off medical care?
DNA-based molecular computing will pave the way for programmable pills
Molecular circuitry offers a better way to measure, and potentially harness, cellular signaling mechanisms.
Your next doctor’s appointment might be with an AI
A new wave of chatbots are replacing physicians and providing frontline medical advice—but are they as good as the real thing?